Controlled substances: gamma-butyrolactone.

{"id": "ocd-bill/853b3684-1d6c-4b51-8562-61cb78bcf082", "session": "20252026", "jurisdiction": {"id": "ocd-jurisdiction/country:us/state:ca/government", "name": "California", "classification": "state"}, "from_organization": {"id": "ocd-organization/98623fa0-f9c3-47ae-80bb-51465349ed71", "name": "Senate", "classification": "upper"}, "identifier": "SB 1306", "title": "Controlled substances: gamma-butyrolactone.", "classification": ["bill"], "subject": ["Controlledsubstances", "gamma-butyrolactone"], "extras": {"tags": ["fiscal committee"], "impact_clause": "An act to add Section 11112 to the Health and Safety Code, relating to controlled substances."}, "created_at": "2026-02-21T08:31:47.708954+00:00", "updated_at": "2026-08-20T09:20:07.811674+00:00", "openstates_url": "https://openstates.org/ca/bills/20252026/SB1306/", "first_action_date": "2026-02-20", "latest_action_date": "2026-08-18", "latest_action_description": "In Senate. Ordered to engrossing and enrolling.", "latest_passage_date": "2026-08-17"}